Top Story

Trumenba provides strong immune response among adolescents, young adults

May 5, 2016

BALTIMORE — Trumenba, a bivalent vaccine for prevention of Neisseria meningitidis serogroup B, appears to safely elicit a robust bactericidal response among adolescents and young adults, according to a pair of phase 3 trials recently presented at the Pediatric Academic Societies Meeting.

Approved by the FDA in 2014, Trumenba (rLP2086, Pfizer) is a three-dose series targeting factor H binding proteins (fHBP), according to the researchers. The CDC’s Advisory Committee on Immunization Practices (ACIP) currently recommends the vaccine be routinely given to at-risk persons aged older than 10 years, and considered for those aged 16 to 23 years in need of short-term meningococcal protection.

Meeting News Coverage

Relapse, readmission similar for asthmatic children treated with dexamethasone vs. prednisone

May 4, 2016
BALTIMORE — Children treated exclusively with dexamethasone or prednisone had similar relapse and readmission rates for asthma, according to findings presented at…
Meeting News Coverage

Preterm birth may affect developmental outcomes later in life

May 4, 2016
BALTIMORE — Despite comparable developmental outcomes at age 24 months, late-preterm children exhibited lower reading and math scores in preschool and kindergarten…
Meeting News CoverageVideo

Increase in fireworks-related injuries among children spurs review of state laws

May 4, 2016
BALTIMORE — Daniel M. Fein, MD, from the Division of Pediatric Emergency Medicine of Children's Hospital at Montefiore and assistant professor of pediatrics at…
In the Journals

CDC estimates 30% of antibiotic prescriptions in US unnecessary

May 4, 2016
Approximately one in three antibiotics prescribed in outpatient settings in the United States are unnecessary, according to recent data published in JAMA.The CDC…
More News Headlines »
Feature Article

Infant Formulas for Food Allergy Treatment and Prevention

Pediatric Annals, April 2016, Volume 45 Issue 4
The number of infant formulas intended for food allergy treatment or prevention has been increasing. Some products…
More »
CME Video

Case Challenges in Pediatric Fatty Liver: What to Look For and When to Refer

This activity is supported by an educational grant from Synageva BioPharma Corp.

Non-alcoholic fatty liver disease (NAFLD) is characterized by excess fat deposition in the liver due to causes other…
More »
PAS 2016

PAS 2016

Meeting News Coverage

VIDEO: Recent progress in development of universal flu vaccine

April 19, 2016
More »
morganatic-roan morganatic-roan